News | January 25, 2012

Crossboss CTO Catheter, Sapien, Watchman Among Picks for Best Cardiac Devices of 2011


January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology category. The expert panel of judges reviewed the nominations for the most significant, innovative and invaluable devices, and the winner and runners-up in the cardiology category are:

Winner

The winner of the cardiology category is the CrossBoss CTO Catheter manufactured by BridgePoint Medical. Which Medical Device Senior Editor for Cardiology Azfar Zaman commends this novel piece of technology with a good success rate in opening chronic occlusions, saying, “It is a quantum leap in the world of CTOs.”

Runner-up

The judges chose both the SAPIEN Transcatheter Heart Valve from Edwards Life Sciences and Medtronic’s Corevalve. The panel commented that, “Both these devices have stood the test of time and the medium term (five years) performance of both valves is sufficiently robust to hope that TAVI may well become the first preferred option in patients with aortic stenosis.”

Special commendations

Special mention is given to the Watchman device from Boston Scientific, which has the potential to improve lives by stopping the need for warfarin in patients with atrial fibrillation.

The judging panel also praised the Absorb Bioresorbable Vascular Scaffold from Abbott Vascular, saying  “We believe that this is the next generation for stents; it promises much but needs to deliver.”

For more information: www.whichmedicaldevice.com, www.sagepublications.com

 


Related Content

News | Heart Valve Technology

Sept. 1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid ...

Home September 04, 2024
Home
News | Heart Valve Technology

June 27, 2024 — The sheer scale of undiagnosed heart valve disease in our aging population has been revealed for the ...

Home June 27, 2024
Home
News | Heart Valve Technology

June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed ...

Home June 21, 2024
Home
News | Heart Valve Technology

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial ...

Home June 10, 2024
Home
News | Heart Valve Technology

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

Home April 17, 2024
Home
News | Heart Valve Technology

April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...

Home April 01, 2024
Home
News | Heart Valve Technology

January 4, 2024 — Findings from a published case series research letter by the Henry Ford Health Structural Heart ...

Home January 04, 2024
Home
News | Heart Valve Technology

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
News | Heart Valve Technology

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S. within the ...

Home December 18, 2023
Home
News | Heart Valve Technology

December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement ...

Home December 12, 2023
Home
Subscribe Now